RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres

Sponsor
Silvia Benemei (Other)
Overall Status
Recruiting
CT.gov ID
NCT03416114
Collaborator
University of Modena and Reggio Emilia (Other), University of Roma La Sapienza (Other), University of Naples (Other), University of Trieste (Other), Maggiore Bellaria Hospital, Bologna (Other), University of L'Aquila (Other)
3,000
1
119
25.2

Study Details

Study Description

Brief Summary

Retro-prospective survey on specific and overall prevalence and incidence of rare primary headaches (Part One, Chapter 3 and Chapter 4, ICHD-3 beta) in patients referred to Italian Tertiary Headache Centres in a 3-year (May 1, 2014-April 30, 2017 - retrospective data) and annually (from May 1, 2017 - prospective data).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    We planned to collect data from May 1, 2014 and afterwards, by means of both retrospective and prospective approaches.

    All patients who have received or will receive a diagnosis of rare primary headache will be asked to participate and, to this aim, to give their informed consent. Each participating Centre should have received the approval of the competent Ethics Committee before commencing any study procedures.

    The registry will contain anagraphic information and data about diagnosis, treatment, comorbidity, and clinical features of the headache. Patients' data will be coded through the Italian Health System unique identifier, in order to avoid duplications of patients referring to more than one Centre and also to monitor multiple referrals.

    A web-based open source platform (SurveyMonkey.org) will be used to collect data.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    3000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary
    Actual Study Start Date :
    Sep 1, 2017
    Anticipated Primary Completion Date :
    Aug 1, 2027
    Anticipated Study Completion Date :
    Aug 1, 2027

    Outcome Measures

    Primary Outcome Measures

    1. Incidence and prevalence in Tertiary headache Centres [10 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • diagnosis of rare primary headaches (Part One, Chapter 3 and Chapter 4, ICHD-3 beta)

    • signed informed consent

    Exclusion Criteria:
    • none

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Careggi University Hospital Florence Italy 50139

    Sponsors and Collaborators

    • Silvia Benemei
    • University of Modena and Reggio Emilia
    • University of Roma La Sapienza
    • University of Naples
    • University of Trieste
    • Maggiore Bellaria Hospital, Bologna
    • University of L'Aquila

    Investigators

    • Study Chair: Silvia Benemei, MD, Careggi University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Silvia Benemei, Researcher, University of Florence
    ClinicalTrials.gov Identifier:
    NCT03416114
    Other Study ID Numbers:
    • RegistRare
    First Posted:
    Jan 30, 2018
    Last Update Posted:
    Jan 30, 2018
    Last Verified:
    Jan 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Silvia Benemei, Researcher, University of Florence
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 30, 2018